US Patent Issued to BMG PHARMA on May 12 for "Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof" (Italian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,129, issued on May 12, was assigned to BMG PHARMA S.P.A. (Torviscosa, Italy).

"Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof" was invented by Marco Mastrodonato (Milan), Luca Stucchi (Torviscosa, Italy), Alessandra Sechi (Torviscosa, Italy), Fabrizio Picotti (Torviscosa, Italy) and Rita Gianni (Monrupino, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a process for the preparation of crosslinked hyaluronic acid butyrate or crosslinked hyaluronic acid butyrate-formate or an acceptable salt thereof, wherein the process comprises the crosslinking reaction of hy...